NCT03937817 Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants Status RECRUITING Phase N/A
NCT03933397 Comparing Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT03919266 Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome. Status COMPLETED Phase NA
NCT03904134 Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) Status COMPLETED Phase NA
NCT03903289 The Implementation of the Automated Erythrocytapheresis in Egyptian Sickle Cell Disease Center Status RECRUITING Phase NA
NCT03903133 Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients Status COMPLETED Phase PHASE4
NCT03886753 Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products Status TERMINATED Phase N/A
NCT03876821 Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research Status COMPLETED Phase N/A
NCT03825341 Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere Status TERMINATED Phase PHASE2
NCT03815695 A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients Status COMPLETED Phase PHASE1
NCT03806452 SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial) Status COMPLETED Phase PHASE2
NCT03805581 Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome Status COMPLETED Phase PHASE2
NCT03786549 Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease Status RECRUITING Phase NA
NCT03758950 Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2 Status COMPLETED Phase PHASE2
NCT03745287 A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease Status COMPLETED Phase PHASE2/PHASE3